Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of SKB118 in advanced solid tumors
CTR20261874Phase 2Active
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical
- Start
- Jun 2026
- Modality
- Vaccines & Immunotherapeutics, Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CR-001 in Nonhematologic neoplasms, sponsored by Sichuan Kelun-Biotech Biopharmaceutical. Started Jun 2026; status: active.
02
Drugs
CR-001
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20261874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261874.